RedHill Biopharma Announces Two New U.S. Patents Covering Opag...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, N.C., Aug. 23, 2021 /PRNewswire-AsiaNet/ -- U.S. patents for opaganib combination for the treatment of Ebola virus disease provides patent protection until 2035Opaganib's 475-patient global Phase 2/3 study in severe COVID-19 approaching completion with upcoming top-line results Opag...
Authors: LATEST ASIANET NEWS RELEASES